Mannkind Corporation (MNKD) is a publicly traded Healthcare sector company. As of May 21, 2026, MNKD trades at $3.32 with a market cap of $923.76M and a P/E ratio of -45.64. MNKD moved +9.46% today. Year to date, MNKD is -42.17%; over the trailing twelve months it is -25.37%. Its 52-week range spans $2.23 to $7.63. Analyst consensus is strong buy with an average price target of $7.54. Rallies surfaces MNKD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MNKD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MNKD recently traded at $3.32. Market cap is $923.76M. P/E ratio is -45.64. Revenue is $360.78M.
| Metric | Value |
|---|---|
| Price | $3.32 |
| Market Cap | $923.76M |
| P/E Ratio | -45.64 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.63 |
| 52-Week Low | $2.23 |
| Volume | 1.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $360.78M |
| Net Income | $-23.91M |
| Gross Margin | 91.53% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $348.97M | $5.86M | $0.02 |
| 2024 | $285.50M | $27.59M | $0.10 |
| 2023 | $198.96M | $-11.94M | $-0.04 |
| 2022 | $99.77M | $-87.40M | $-0.34 |
8 analysts cover MNKD: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.54.